Brief: Avenue Therapeutics Announces Pricing Of $12 Million Underwritten Public Offering
Oct 6 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS ANNOUNCES PRICING OF $12 MILLION
UNDERWRITTEN PUBLIC OFFERING
* ANNOUNCED PRICING OF ITS UNDERWRITTEN PUBLIC OFFERING OF
3.6
MILLION COMMON AND PRE-FUNDED UNIT
* AVENUE THERAPEUTICS - EACH SHARE OF COMMON STOCK IS BEING
SOLD
TOGETHER WITH ONE WARRANT AT A COMBINED PURCHASE PRICE OF $3.30/
UNIT
Source text for Eikon: ID:nGNX7wThBq
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary